Medreich Limited — Salicylic Exporter Profile
Indian Pharmaceutical Exporter · #5 for Salicylic · $1.0M export value · DGFT Verified
Medreich Limited is the #5 Indian exporter of Salicylic with $1.0M in export value and 77 verified shipments. Medreich Limited holds a 6.0% market share in Salicylic exports across 9 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Salicylic Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Salicylic?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $349.7K | 35 | 35.6% |
| UNITED ARAB EMIRATES | $303.5K | 25 | 30.9% |
| BANGLADESH | $212.2K | 8 | 21.6% |
| JORDAN | $50.0K | 1 | 5.1% |
| DENMARK | $25.5K | 4 | 2.6% |
| ETHIOPIA | $18.6K | 1 | 1.9% |
| ZIMBABWE | $11.3K | 1 | 1.2% |
| CAMBODIA | $9.0K | 1 | 0.9% |
| AFGHANISTAN | $2.7K | 1 | 0.3% |
Medreich Limited exports Salicylic to 9 countries. The largest destination is NETHERLANDS accounting for 35.6% of Medreich Limited's Salicylic shipments, followed by UNITED ARAB EMIRATES (30.9%) and BANGLADESH (21.6%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Salicylic from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| IMRES B V | NETHERLANDS | $349.7K | 35 |
| IMPERIAL MEDRICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $231.0K | 20 |
| WORLD HEALTH ORGANIZATION DHAKA | BANGLADESH | $212.2K | 8 |
| WORLD HEALTH ORGANIZTION JORDAN | JORDAN | $50.0K | 1 |
| IMPERIAL MEDICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $49.2K | 2 |
| UNICEF SUPPLY DIVISION | DENMARK | $25.5K | 4 |
| AL RAAYA DRUG STORE-UAE-AL AIN | UNITED ARAB EMIRATES | $23.2K | 3 |
| MINISTRY OF HEALTH | ETHIOPIA | $18.6K | 1 |
| MINISTRY OF HEALTH AND CHILD WELFAR | ZIMBABWE | $11.3K | 1 |
| MOPOTSYO-PATIENT INFORMATION CENTRE | CAMBODIA | $9.0K | 1 |
Medreich Limited supplies Salicylic to 11 buyers globally. The largest buyer is IMRES B V (NETHERLANDS), followed by IMPERIAL MEDRICAL SOLUTIONS FZE (UNITED ARAB EMIRATES) and WORLD HEALTH ORGANIZATION DHAKA (BANGLADESH). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Salicylic Export Value and How Much Does Medreich Limited Contribute?
India exported $12.5M worth of Salicylic through 2,799 shipments from 276 suppliers to 132 countries, serving 632 buyers globally. Medreich Limited contributes $1.0M to this total, accounting for 6.0% of India's Salicylic exports. Medreich Limited ships Salicylic to 9 countries through 11 buyers.
What Is the Average Shipment Value for Medreich Limited's Salicylic Exports?
Medreich Limited's average Salicylic shipment value is $13.2K per consignment, based on 77 shipments totaling $1.0M. The largest destination is NETHERLANDS (35.6% of Medreich Limited's Salicylic exports).
How Does Medreich Limited Compare to Other Indian Salicylic Exporters?
Medreich Limited ranks #5 among 276 Indian Salicylic exporters with a 6.0% market share. The top 3 exporters are RECKITT BENCKISER (INDIA) PRIVATE LIMITED ($3.6M), RECKITT BENCKISER INDIA PRIVATE LIMITED ($2.2M), CIPLA LIMITED ($2.0M). Medreich Limited processed 77 shipments to 9 destination countries.
What Salicylic Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ACETYL SALICYLIC ACID 75MG TABLETS 1X2 | $183.1K | 10 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28 | $169.7K | 11 |
| ACETYL SALICYLIC ACID 75 MG TABLETS 1X28 | $58.8K | 3 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S(388393 PACKS) | $50.0K | 1 |
| ACETYL SALICYLIC ACID 75 MG TABLETS 1X2 | $46.3K | 2 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (208412 PACKS) | $44.5K | 3 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (156461 PACKS) | $33.6K | 1 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (156156 PACKS) | $33.0K | 1 |
| ACETYL SALICYLIC ACID 75MG TABLETS 1X28S (156533 PACKS) | $33.0K | 1 |
| ACETYL SALICYLIC ACID 75 MG TABLETS 1X28S 154920 PACKS | $29.6K | 1 |
Medreich Limited exports 38 distinct Salicylic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ACETYL SALICYLIC ACID 75MG TABLETS 1X2 with 10 shipments worth $183.1K.
How Does Medreich Limited Compare to Nearest Salicylic Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | RECKITT BENCKISER INDIA PRIVATE LIMITED | $2.2M | 86 | 1 | $25.6K |
| 3 | CIPLA LIMITED | $2.0M | 121 | 3 | $16.3K |
| 5 | MEDREICH LIMITED ★ | $1.0M | 77 | 9 | $13.2K |
| 6 | AUROBINDO PHARMA LTD | $745.3K | 40 | 2 | $18.6K |
| 7 | ACME GENERICS PRIVATE LIMITED | $686.1K | 19 | 1 | $36.1K |
Medreich Limited ranks #5 among 276 Indian Salicylic exporters. Average shipment value of $13.2K compared to the market average of $45.4K. The closest competitors by value are RECKITT BENCKISER INDIA PRIVATE LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Salicylic Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 412 | 14.7% |
| BANGALORE ICD | 324 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 319 | 11.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 268 | 9.6% |
| DELHI AIR | 201 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 134 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 111 | 4.0% |
| JNPT | 109 | 3.9% |
Geopolitical & Trade Policy Impact on Medreich Limited's Salicylic Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Salicylic, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salicylic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salicylic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 77 individual customs records matching Medreich Limited exporting Salicylic, covering 38 formulations to 9 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 132+ countries, 632+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salicylic Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Salicylic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Salicylic Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salicylic. For current shipment-level data, contact TransData Nexus.